Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Pemetrexed in Advanced Biliary Tract and Gallbladder Carcinoma
NCT00059865Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Jan 2004
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in biliary tract carcinoma (BTC), gallbladder carcinoma, sponsored by Cancer and Leukemia Group B. Started Jan 2004; status: completed.
02
Drugs
pemetrexed
03
Conditions
biliary tract carcinoma (BTC)gallbladder carcinoma
Beyond the preview
Go deeper on NCT00059865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00059865.